As of May 25
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +569.64% increase from the last price of 2.24.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.